Researchers have developed a patch for easier and more effective treatment of psoriasis. The method may also be used in treatment of other inflammatory skin diseases.

Researchers at the University of Copenhagen have developed a patch for easier and more effective treatment of psoriasis. The ...

Researchers at the University of Copenhagen have developed a patch for easier and more effective treatment of psoriasis. The ...

We also discussed peptides and stem cells and how we can use all these cutting-edge treatments to optimize my health ... She ...

Researchers from the National Defense Medical Center in Taiwan have identified an increased risk of psoriasis in patients ...

AbbVie is reaching for the Sky(rizi) as it spent a staggering $51.5 million on TV drug ads for its immunology blockbuster in October. | AbbVie is reaching for the Sky(rizi) as it spent a staggering ...

Exacerbations of the chronic and progressive inflammatory disease bronchiectasis can impact quality of life. Treatment, based ...

Third quarter net product revenues for ZORYVE® (roflumilast) franchise of $44.8M, with $22.0M for ZORYVE cream 0.3%, $20.3M for ZORYVE topical ...

In Oregon, there may be some relief coming from the Legislature. Maybe. A state board, the Oregon Drug Prescription ...

The Food and Drug Administration (FDA) has approved Imuldosa ™ (ustekinumab ... is a human interleukin-12 and -23 antagonist indicated for the treatment of: Moderate to severe plaque psoriasis in ...

Research shows lifestyle changes like diet, exercise, and smoking cessation can assist with improving psoriasis outcomes and ...

Medically reviewed by Casey Gallagher, MD Psoriasis of the hands and feet, known as palmoplantar psoriasis, is an inflammatory autoimmune disorder that causes scaly, itchy skin patches on the palms ...